Functions of natural killer cells

Natural killer (NK) cells are effector lymphocytes of the innate immune system that control several types of tumors and microbial infections by limiting their spread and subsequent tissue damage. Recent research highlights the fact that NK cells are also regulatory cells engaged in reciprocal interactions with dendritic cells, macrophages, T cells and endothelial cells. NK cells can thus limit or exacerbate immune responses. Although NK cells might appear to be redundant in several conditions of immune challenge in humans, NK cell manipulation seems to hold promise in efforts to improve hematopoietic and solid organ transplantation, promote antitumor immunotherapy and control inflammatory and autoimmune disorders.

[1]  K. Wucherpfennig,et al.  Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. , 2007, Immunity.

[2]  M. Smyth,et al.  CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer1 , 2006, The Journal of Immunology.

[3]  A. Fischer Human primary immunodeficiency diseases. , 2007, Immunity.

[4]  L. Lanier,et al.  Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Christophe Benoist,et al.  Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  U. V. Andrian,et al.  T cell– and B cell–independent adaptive immunity mediated by natural killer cells , 2006, Nature Immunology.

[7]  Diego Piccioli,et al.  Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells , 2002, The Journal of experimental medicine.

[8]  D. Fremont,et al.  Recognition of a virus-encoded ligand by a natural killer cell activation receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Janka Hemophagocytic syndromes. , 2007, Blood reviews.

[10]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[11]  R. Vance,et al.  Self-tolerance of natural killer cells , 2006, Nature Reviews Immunology.

[12]  R. Jaffe Decidual NK cells regulate key developmental processes at the human fetal-maternal interfaceHanna J, Goldman-Wohl D, Hamani Y, et al (Hebrew Univ-Hadassah Med School, Jerusalem; Hadassah Univ Hosp-Mount Scopus, Jerusalem; Ben Gurion Univ, Beer Sheva, Israel) Nature Med 12:1065–1074, 2006§ , 2008 .

[13]  I. Weissman,et al.  In vivo natural killer cell activities revealed by natural killer cell-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[15]  L. Lanier,et al.  Suppression of tumor formation in lymph nodes by L-selectin–mediated natural killer cell recruitment , 2005, The Journal of experimental medicine.

[16]  M. Martelli,et al.  Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self , 2006, Immunological reviews.

[17]  L. Racioppi,et al.  Natural killer cells in vernal keratoconjunctivitis. , 2007, Molecular vision.

[18]  C. Münz,et al.  NK Cell Compartments and Their Activation by Dendritic Cells1 , 2004, The Journal of Immunology.

[19]  Eric Vivier,et al.  Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46 , 2007, Proceedings of the National Academy of Sciences.

[20]  M. Smyth,et al.  CD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity1 , 2006, The Journal of Immunology.

[21]  J. Orange Human natural killer cell deficiencies , 2006, Current opinion in allergy and clinical immunology.

[22]  W. Carson,et al.  Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. , 2002, Surgery.

[23]  R. Sun,et al.  Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D‐ligand interaction and natural killer cells , 2007, Hepatology.

[24]  P. Debré,et al.  NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Rieben,et al.  Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. , 2005, Trends in immunology.

[26]  Antonio Lanzavecchia,et al.  Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming , 2004, Nature Immunology.

[27]  G. Trinchieri,et al.  The Reciprocal Interaction of NK Cells with Plasmacytoid or Myeloid Dendritic Cells Profoundly Affects Innate Resistance Functions1 , 2005, The Journal of Immunology.

[28]  M. Smyth,et al.  Close encounters of different kinds: Dendritic cells and NK cells take centre stage , 2005, Nature Reviews Immunology.

[29]  K. Takeda,et al.  The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms , 1993, The Journal of experimental medicine.

[30]  A. Diefenbach,et al.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15. , 2007, Immunity.

[31]  A. Diefenbach,et al.  Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity , 2001, Nature.

[32]  M. Degli-Esposti,et al.  The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection , 2007, Immunology and cell biology.

[33]  C. Gardiner,et al.  TLR7/8-Mediated Activation of Human NK Cells Results in Accessory Cell-Dependent IFN-γ Production1 , 2005, The Journal of Immunology.

[34]  Moses Rodriguez,et al.  Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. , 1989, Journal of immunology.

[35]  M. Caligiuri,et al.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. , 2003, Blood.

[36]  S. Spector,et al.  Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. , 2008, Blood.

[37]  J. Bienenstock,et al.  Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria , 1982, The Journal of experimental medicine.

[38]  K. Ley,et al.  Trafficking of natural killer cells. , 2004, Current molecular medicine.

[39]  L. Zitvogel,et al.  Natural-killer cells and dendritic cells: "l'union fait la force". , 2005, Blood.

[40]  H. Broxmeyer,et al.  CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. , 1999, Cellular immunology.

[41]  M. Smyth,et al.  Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells , 2004, The Journal of experimental medicine.

[42]  D. Nixon,et al.  Cutting Edge: KIR3DS1, a Gene Implicated in Resistance to Progression to AIDS, Encodes a DAP12-Associated Receptor Expressed on NK Cells That Triggers NK Cell Activation1 , 2007, The Journal of Immunology.

[43]  F. Sutterwala,et al.  Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ , 2005, Nature Immunology.

[44]  P. Borrow,et al.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage , 2007, The Journal of experimental medicine.

[45]  Eric O Long Ready for prime time: NK cell priming by dendritic cells. , 2007, Immunity.

[46]  C. Münz,et al.  NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN‐γ secretion , 2006 .

[47]  M. Smyth,et al.  Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection , 2002, Nature Immunology.

[48]  Peter Chen,et al.  Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. , 2007, Immunity.

[49]  J. Chewning,et al.  Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands1 , 2007, The Journal of Immunology.

[50]  G. Trinchieri,et al.  Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. , 2002, The Journal of experimental medicine.

[51]  C. Le,et al.  Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. , 2005, Blood.

[52]  W. Murphy,et al.  Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. , 2001, Blood.

[53]  Eric O Long,et al.  Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. , 2006, Blood.

[54]  William H. Carr,et al.  Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes , 2007, The Journal of experimental medicine.

[55]  L. Moretta,et al.  Effector and regulatory events during natural killer–dendritic cell interactions , 2006, Immunological reviews.

[56]  R. Vance,et al.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. , 2005, Blood.

[57]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[58]  D. Tough,et al.  In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection , 2007, Immunology.

[59]  L. Lanier,et al.  NK cell recognition of mouse cytomegalovirus-infected cells. , 2006, Current topics in microbiology and immunology.

[60]  N. Sarvetnick,et al.  Target cell defense prevents the development of diabetes after viral infection , 2002, Nature Immunology.

[61]  D. Middleton,et al.  Human NK cell education by inhibitory receptors for MHC class I. , 2006, Immunity.

[62]  X. Li,et al.  NK cells promote transplant tolerance by killing donor antigen-presenting cells , 2006, The Journal of experimental medicine.

[63]  J. Trowsdale,et al.  Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. , 2007, Blood.

[64]  A. Fauci,et al.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[65]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[66]  C. Stewart,et al.  Strategies of Natural Killer (NK) Cell Recognition and Their Roles in Tumor Immunosurveillance , 2008 .

[67]  B. Devulder L'union fait la force… , 1994 .

[68]  B. Beutler,et al.  Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis , 2007, The Journal of Experimental Medicine.

[69]  M. Parmentier,et al.  The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. , 2007, Blood.

[70]  M. Smyth,et al.  NKG2D function protects the host from tumor initiation , 2005, The Journal of experimental medicine.

[71]  N. Rose,et al.  From infection to autoimmunity. , 2001, Journal of autoimmunity.

[72]  G. Trinchieri,et al.  Interferon (cid:2) / (cid:3) and Interleukin 12 Responses to Viral Infections: Pathways Regulating Dendritic Cell Cytokine Expression In Vivo , 2002 .

[73]  P. Andrew,et al.  Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts. , 2005, Microbes and infection.

[74]  P. Parham MHC class I molecules and kirs in human history, health and survival , 2005, Nature Reviews Immunology.

[75]  J. Hanna,et al.  Decidual NK cells regulate key developmental processes at the human fetal-maternal interface , 2006, Nature Medicine.

[76]  K. Gagne,et al.  KIR matching in hematopoietic stem cell transplantation. , 2005, Current opinion in immunology.

[77]  J. Carulli,et al.  Inflammatory arthritis can be reined in by CpG-induced DC–NK cell cross talk , 2007, The Journal of experimental medicine.

[78]  U. Koszinowski,et al.  Natural Killer Cells Promote Early CD8 T Cell Responses against Cytomegalovirus , 2007, PLoS pathogens.

[79]  H. Ljunggren,et al.  Prospects for the use of NK cells in immunotherapy of human cancer , 2007, Nature Reviews Immunology.

[80]  D. Raulet Interplay of natural killer cells and their receptors with the adaptive immune response , 2004, Nature Immunology.

[81]  R. Schreiber,et al.  Perforin and granzymes have distinct roles in defensive immunity and immunopathology. , 2006, Immunity.

[82]  K. Nakachi,et al.  Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population , 2000, The Lancet.

[83]  H. Ljunggren,et al.  Natural killer and dendritic cell contact in lesional atopic dermatitis skin--Malassezia-influenced cell interaction. , 2002, The Journal of investigative dermatology.

[84]  A. Yamauchi,et al.  Fractalkine-Mediated Endothelial Cell Injury by NK Cells1 , 2000, The Journal of Immunology.

[85]  C. Nguyen,et al.  CD8 T Cell Help for Innate Antitumor Immunity1 , 2007, The Journal of Immunology.

[86]  M. Caligiuri,et al.  Human natural killer cell development , 2006, Immunological reviews.

[87]  C. Bieberich,et al.  Natural Killer Cell Tolerance in Mice with Mosaic Expression of Major Histocompatibility Complex Class I Transgene , 1997, The Journal of experimental medicine.

[88]  L. Lybarger,et al.  Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.

[89]  L. Felländer-Tsai,et al.  Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion , 2007, Immunology.

[90]  L. Moretta,et al.  CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[91]  Eric Vivier,et al.  Natural Killer Cell Signaling Pathways , 2004, Science.

[92]  J. Wagner,et al.  Good manufacturing practices production of natural killer cells for immunotherapy: a six‐year single‐institution experience , 2007, Transfusion.

[93]  É. Vivier,et al.  Natural killer cells and malaria , 2006, Immunological reviews.

[94]  W. Yokoyama,et al.  In vivo developmental stages in murine natural killer cell maturation , 2002, Nature Immunology.

[95]  H. Hall,et al.  NK cells: elusive players in autoimmunity. , 2005, Trends in immunology.

[96]  E. Riley,et al.  Natural killer cells and innate immunity to protozoan pathogens. , 2004, International journal for parasitology.

[97]  C. Tayade,et al.  Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones , 2006, Immunological reviews.

[98]  S. Hiby,et al.  How Does the maternal immune system contribute to the development of pre-eclampsia? , 2007, Placenta.

[99]  Yannick Jacques,et al.  Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor , 2007, Nature Immunology.

[100]  L. Lanier,et al.  Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell–mediated innate resistance to cytomegalovirus infection , 2005, Nature Genetics.

[101]  C. Biron,et al.  Keeping NK cells in highly regulated antiviral warfare. , 2007, Trends in immunology.

[102]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[103]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[104]  B. Plougastel,et al.  Immune functions encoded by the natural killer gene complex , 2003, Nature Reviews Immunology.

[105]  G. Girolomoni,et al.  CD56brightCD16– NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation , 2006, European journal of immunology.

[106]  Todd A Fehniger,et al.  Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. , 2007, Immunity.

[107]  H. Ljunggren,et al.  NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell Vaccination Efficacy 1 , 2004, The Journal of Immunology.

[108]  J. Dorfman,et al.  Turnover and Proliferation of NK Cells in Steady State and Lymphopenic Conditions1 , 2004, The Journal of Immunology.

[109]  P. Marrack,et al.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. , 2004, Blood.

[110]  M. McNerney,et al.  A new self: MHC-class-I-independent Natural-killer-cell self-tolerance , 2005, Nature Reviews Immunology.

[111]  J. Blay,et al.  CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner , 2005, The Journal of experimental medicine.